{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:09:08Z","timestamp":1795122548704,"version":"4.10.3"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Peritoneal cancer index is an integral parameter for preoperative assessment of peritoneal disease. Current imaging modalities including <jats:sup>18<\/jats:sup>F-FDG PET\/CT, though superior to CT, underestimate the disease extent, mainly due to its high physiological background activity. Novel \u201ccancer integrin\u201d targeting imaging with <jats:sup>68<\/jats:sup>Ga-trivehexin demonstrates limited physiological activity in the abdomen with superior target-to-background ratio than <jats:sup>18<\/jats:sup>F-FDG PET\/CT. Thus, we describe the first case demonstrating potential utility of novel \u201ccancer integrin\u201d \u03b1v\u03b26 imaging agent <jats:sup>68<\/jats:sup>Ga-trivehexin for assessment of disease burden in advanced epithelial ovarian cancer.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005485","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T14:00:20Z","timestamp":1728050420000},"page":"e619-e621","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["\u201cCancer Integrin\u201d \u03b1v\u03b26 Imaging With 68Ga-Trivehexin PET\/CT in Assessment of Ovarian Carcinoma"],"prefix":"10.1097","volume":"49","author":[{"given":"Parneet","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanhaiyalal","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Emerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Baranwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Sai Sradha","family":"Patro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish Kumar","family":"Parida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0090-8258(03)00278-6","article-title":"Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study","volume":"90","year":"2003","journal-title":"Gynecol Oncol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.21037\/qims-20-784","article-title":"Diagnostic accuracy of (18)F-FDG PET\/CT scan for peritoneal metastases in advanced ovarian cancer","volume":"11","year":"2021","journal-title":"Quant Imaging Med Surg"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s13193-019-00914-9","article-title":"Accuracy of CT scan in predicting the surgical PCI in patients undergoing cytoreductive surgery with\/without HIPEC\u2014a prospective single institution study","volume":"10","year":"2019","journal-title":"Indian J Surg Oncol"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/RLU.0000000000000768","article-title":"Peritoneal carcinomatosis in primary ovarian cancer staging: comparison between MDCT, MRI, and 18F-FDG PET\/CT","volume":"40","year":"2015","journal-title":"Clin Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"743","DOI":"10.21037\/qims.2020.02.19","article-title":"Preoperative PET\/CT score can predict complete resection in advanced epithelial ovarian cancer: a prospective study","volume":"10","year":"2020","journal-title":"Quant Imaging Med Surg"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2013.08.023","article-title":"A prospective comparison of integrated FDG-PET\/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer","volume":"131","year":"2013","journal-title":"Gynecol Oncol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1097\/RLU.0000000000004417","article-title":"Development and validation of 18F-FDG PET\/CT-based models for predicting successful complete cytoreduction during primary cytoreductive surgery for advanced ovarian cancer","volume":"48","year":"2023","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/RLU.0000000000003785","article-title":"Performance of multiparametric functional imaging to assess peritoneal tumor burden in ovarian cancer","volume":"46","year":"2021","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005485","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:07:38Z","timestamp":1750532858000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":8,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005485","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,3]]}}}